Advanced
Part of Thermo Fisher Scientific
Thermo Scientific - Pierce Protein Research Products  

Document Center

  Certificate of Analysis
  Product Instructions
  MSDS
  Request a Catalog

User Profile

Email Address:
Password:
 
  Forgot Password
  Register
  Why Register?

Shopping Cart

 Cart is Empty
 Quick Order
  Ordering Information
Shipping & Handling
Returns Info
Security Info
Terms & Conditions



Email Sign-up  Email Sign-up

Subscribe to our RSS feed!  RSS

Follow us on Facebook  Follow Us


 




 MA(PEG)n PEGylation Reagents 

Discrete-length polyethylene glycol compounds with a terminal primary amine.

MA(PEG)n is the abbreviation for a set of compounds having polyethylene glycol (PEG) spacers and terminal methyl (-CH3) and amino (-NH2) groups. The unbranched, hydrophilic, discrete-length molecules have the form Methyl-PEGn-Amine, where the subscript "n" denotes 4, 8, 12, or 24 ethylene glycol units. The terminal primary amine of each compound provides a specific target for crosslinking and other conjugation methods, making these compounds useful as PEGylation reagents.

MA(PEG)n, Methyl-Amine PEGylation Reagents

Methods of covalent attachment:

  • Conjugate to carboxyl groups using EDC
  • Crosslink to primary amines using DSS, BS(PEG)n or other NHS ester reagent
  • Crosslink to sulfhydryl groups using Sulfo-SMCC or SM(PEG)n reagent
  • Attach to oxidized carbohydrate groups (aldehydes) by reductive amination

Alternative names
for MA(PEG):

  • M-dPEG-amine
  • Methyl-PEO-amine
  • Amino-dPEG-m
  • Amino-PEG 600
  • Amine-modified PEG

Applications of PEGylation:

  • PEGylate carboxylate or amine surfaces
  • Add inert mass to proteins, immunogens, drug compounds and probes
  • Improve solubility (decrease aggregation) of proteins or peptides without affecting function
  • Protect proteins from proteolysis

Why PEGylate a protein or peptide?

Methyl-capped PEG-containing reagents have been used to modify proteins to provide specific advantages. Protein PEGylation can improve the stability of the modified protein, protect it from proteolytic digestion, increase its half life in a biological application, mask it from causing an immunogenic response, decrease its antigenicity or potential toxicity, improve its solubility, diminish the potential for aggregation, and minimize interference for both in vitro and in vivo applications. Polyethylene glycol, also called polyethylene oxide (PEO), has these effects because it is nontoxic, nonimmunogenic, hydrophilic, water soluble and highly flexible.

Advantages of Discrete-length Polyethylene Glycol Compounds

These reagents are specially synthesized, resulting in homogeneous compounds of defined molecular weight, characterized by discrete chain lengths, providing a greater ability to optimize and characterize surface protein modifications. Typical preparations of PEG compounds are a heterogeneous mixtures composed of a distribution of chain lengths with a specified average molecular weight or approximate number of PEG subunits.

Highlights:

  • Fully characterized PEGylation reagents with defined PEG chain lengths; molecules of discrete molecular weights for consistency of performance in protein-modification applications
  • Provided as a series of 4, 8, 12 and 24 ethylene glycol units, enabling modification procedures to be optimized for a specific application while retaining all the benefits associated with protein PEGylation
  • PEG spacer provides unique advantages, including increased stability, reduced tendency toward aggregation and reduced immunogenicity
  • Allows site-specific labeling of primary amines or carboxyl groups on proteins or surfaces
  • Easy-to-follow instructions increase the likelihood of a successful outcome

Related Products

Carboxyl-PEG-Amine Compounds, CA(PEG)n
Other Kinds of PEGylation Reagents

References

  1. Hermanson, G.T. (2008). Bioconjugate Techniques, Academic Press (Product # 20036)
  2. Harris, J. M. and Zalipsky, S. Eds (1997). Poly(ethylene glycol), Chemistry and Biological Applications, ACS Symposium Series, 680.
  3. Harris, J. M. and Kozlowski, A. (2001). Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C. J. Control Release 72, 217-224.
  4. Veronese, F. and Harris, J.M. Eds. (2002). Peptide and protein PEGylation. Advanced Drug Delivery Review 54(4), 453-609.

PEGylation reagents are available in bulk quantities with special pricing for manufacturing applications.



Ordering Information
Bulk quantities: InquireBulk quantities: Inquire    Certificate of AnalysisCertificate of Analysis   Product InstructionsProduct Instructions   MSDSMSDS
Product # Description Pkg. Size Files Price
26110 MA(PEG)4 100 mg Product Instructions MSDS for product # 26110 MA(PEG)4 $155.00

26111 MA(PEG)4 1 g Product Instructions MSDS for product # 26111 MA(PEG)4 $675.00

26112 MA(PEG)8 100 mg Product Instructions MSDS for product # 26112 MA(PEG)8 $206.00

26113 MA(PEG)8 1 g Product Instructions MSDS for product # 26113 MA(PEG)8 $850.00

26114 MA(PEG)12 100 mg Product Instructions MSDS for product # 26114 MA(PEG)12 $258.00

26115 MA(PEG)12 1 g Product Instructions MSDS for product # 26115 MA(PEG)12 $925.00

26116 MA(PEG)24 100 mg MSDS for product # 26116 MA(PEG)24 Product Instructions $258.00

26117 MA(PEG)24 1 g MSDS for product # 26117 MA(PEG)24 Product Instructions $1,150.00


Learn more about other Thermo Scientific Life Science Research Products
Biopolymers Cell Culture High Content Screening  
Nucleic Acid Technologies PCR Reagents & Plastics RNAi Technologies  European Sales

 © 2010 Thermo Fisher Scientific Inc.

PO Box 117, Rockford, IL 61105 USA
1-800-874-3723  or  815-968-0747

Trademarks Privacy Statement